Evaluation of efficacy and safety of budesonide delivered via two dry powder inhalers

By Kerwin Edward M.   Pearlman David S.   de Guia Teresita   Carlsson Lars-Göran   Gillen Michael   Uryniak Tom   Simonson Steven G.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1497-1510

Informa Healthcare

Access to resources Recommend Favorite

Inhalation devices for long-acting β₂-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD

By Molimard Mathieu   Till Denise   Stenglein Stephan   Singh Dilraj   Krummen Markus  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2405-2413

Informa Healthcare

Access to resources Recommend Favorite

Variability of fine particle dose and lung deposition of budesonide delivered through two multidose dry powder inhalers

By Munzel U.   Marschall K.   Fyrnys B.   Wedel M.  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 827-834

Informa Healthcare

Access to resources Recommend Favorite

Moving from CFC Aerosol to HFA Aerosol or Dry Powder Inhalers: What Do Patients Think?

By  

Respiration, Vol. 69, Iss. 4, 2002-07 ,pp. : 314-319

Karger

Access to resources Recommend Favorite

Therapeutic Equivalence and Acceptability of Two Multidose Powder Inhalers in the Treatment of Asthma

By  

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 77-82

Karger

Access to resources Recommend Favorite